comparemela.com

Shawm Durvalulmab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Durvalumab Confirmed Beneficial After NSCLC Chemoradiotherapy

This analysis evaluated patient-related outcomes between those who did and did not receive consolidation durvalumab after chemoradiotherapy for unresectable stage III non–small cell lung cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.